Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE

Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
Real world data in real time
How eCOAs are changing the clinical research workflow
Frederic Sibeaud, Director, eCOA Data Management
Oct 25, 2021
  • Blogs
  • Real world data in real time

Electronic clinical outcomes assessments (eCOAs) don’t just simplify data collection. They give researchers almost instant access to patient data, which accelerates their ability to identify trends and make decisions. The impact of this speed and agility on a trial is that months can be cut from the duration, while lowering costs and mitigating risks, giving sponsors a powerful new tool in the clinical landscape.

Paper takes forever

With traditional paper-based diaries, researchers have to wait weeks to collect data when patients submit them at on-site appointments. Those paper documents can then pile up for weeks before they are transcribed into the database for review.

That means researchers may wait months before they can review any patient reported outcomes (PROs) from the trial population. It’s a significant front-end delay that adds weeks to the trial and slows decision-making.

With eCOAs that process is transformed. eCOAs are digital assessment tools that capture data directly from the patient via virtual questionnaires and diaries. As soon as the data is recorded, it is transported to the trial database, with no transcription or data transfer steps required.

That means researchers and sponsors can begin assessing PROs on day one of the trial. The impact can be profound.

The many benefits of eCOA

That near real time insight can help sponsors create safer trials, while providing financial and strategic benefits that may give them an edge in the marketplace. These benefits allow sponsors to:

  • Speed start up. IQVIA has a library of existing eCOAs, and an agile development process that allows sponsors to build custom eCOAs almost overnight. This can cut 12+ weeks from the upfront development process compared to other eCOA providers, enabling sponsors to launch trials faster, potentially shortening the trial and accelerating time to market.
  • Adapt to subpopulations of interest. If sponsors are following an adaptive trial design, eCOA data can help them identify sub-populations who are experiencing better (or worse) results early in the trial, allowing them to shift course midstream. This early data may drive them to add or drop arms, adapt protocols, or modify inclusion/exclusion criteria to draw those patients most likely to respond to the treatment. That can help them generate the best possible results for their regulatory submissions.
  • Predict potential risks before they become serious. Early PRO data collection allows researchers to monitor patients and detect trends, such as poor sleep or increased pain. Because the data is instantly available for analysis, researchers can identify potential risks sooner so they can respond proactively.
  • Reduce required population size. If early eCOA data strongly indicates that safety and efficacy endpoints are being met in existing patients, the sponsor may choose to cap recruiting because the data verifies the expected outcomes.
  • Make faster go/no go decisions. If a treatment isn’t working as expected, having rapid access to eCOA data can accelerate a sponsor’s decision to cut their losses. This can save sponsors millions of dollars, which could be funneled to other promising drug candidates.
  • Beat competitors to market. The rapid start up and speed to data can potentially shorten the trial and accelerate a drug’s path to market. This not only cuts the cost of the trial, it could help sponsors establish themselves as the first treatment in the market to address an unmet medical need. The impact of that can be huge. First-in-class drugs are more likely to be established as the standard of care, and to have a greater market-share advantage. One study found that when the first mover is a large pharma company, that advantage is worth greater than ten market-share points.
  • Stay connected with remote patients. The Pandemic forced many sponsors to adopt decentralized clinical trials (DCT), using telehealth, home health, and remote data collection. eCOAs gave them the tools to continue to monitor the patient experience, and to provide another conduit for patients to share data and stay engaged in the trial. DCTs are expected to be a permanent part of the trial landscape going forward, making eCOAs an important tool for patient engagement.

Regulators and patients expect the patient’s perspective to be represented in clinical research. eCOAs give sponsors a way to capture that perspective quickly and concisely, while accelerating their ability to make decisions about the benefits of the therapy. The speed and agility eCOAs provide benefits everyone in the clinical landscape, making them an essential part of the future of clinical research.

Related solutions

eCOA

Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.

eCOA FAQ

Explore our Frequently Asked Questions (FAQ) page to learn more about general industry eCOA topics and also specific details about our IQVIA eCOA solution.

eCOA Demo Videos

In these short demo videos, learn more about some of the key capabilities within the IQVIA eCOA platform including how to easily create an assessment, utilize the AI design tool, access automated screenshots and documentation, export/import translations, and view study data and reports.

Patient Engagement Suite

Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.

IQVIA Technologies

Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.

Contact Us